Dr. Anais A. Ovalle, MD

Dr. Ovalle practices at Kent Hospital in Warwick, Rhode Island, part of Care New England Health System.

Dr. Ovalle's NPI, 1396127189, was assigned on June 29, 2015. Dr. Ovalle graduated from Geisel School of Medicine at Dartmouth in 2022. Dr. Ovalle holds New Hampshire license 22404.

Dr. Ovalle's primary practice is Kent Hospital, at 455 Toll Gate Rd, Warwick, RI 02886 in Kent County. The practice phone is (401) 737-7010.

Dr. Ovalle's primary practice is Kent Hospital in Warwick, Rhode Island, part of Care New England Health System. Dr. Ovalle is also affiliated with Dartmouth Hitchcock Medical Center. The medical group on file is Dartmouth Hitchcock Medical Center. Dmand AI also links Dr. Ovalle to 1 more hospital and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ovalle practices, 3 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Ovalle's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dmand AI has Dr. Ovalle's licenses on file in 2 states: New Hampshire and Rhode Island.

CMS data shows 205 Medicare services from Dr. Ovalle across 5 procedure codes in 2024, for 153 Medicare patients. Medicare paid $18,414 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 153 Medicare patients who saw Dr. Ovalle in 2024. The largest group is 65 to 74, with 53 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 2.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ovalle's median patient age at 56, with 52% women.

In 2024, Dr. Ovalle wrote 285 Medicare Part D claims for 106 patients. 91% of them were for generic drugs. CMS names the drug for 81 of them, across 6 drugs with 11 or more claims each, at $1,497 in total drug cost. In 2023, CMS named 30 claims across 2 drugs.

Dr. Ovalle accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ovalle as offering telehealth.

Dmand AI links 15 papers to Dr. Ovalle, published from 2016 to 2025. 2021 was the busiest year, with 3. The most frequent topics are Hospital Mortality and Length of Stay. Dr. Ovalle's most frequent co-authors are Osama Siddique, MD, David De Gijsel, MD and Thomas Fekete, MD.

CMS Open Payments shows 1 general payment to Dr. Ovalle from 1 drug or device company in 2023. Food and beverage make up the largest share, 100% of the total. Teva Pharmaceuticals USA, Inc. paid the most, $136.

Dr. Ovalle graduated from Geisel School of Medicine at Dartmouth in 2022.